Physician profile
David Bruce Glover
NPI 1538103569
$528.89
in general payments reported to CMS, 2019-2025
13 companies · $60.91 in 2025
The $60.91 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.04 · 2020: $30.02 · 2021: $93.05 · 2022: $110 · 2023: $98.09 · 2024: $110 · 2025: $60.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $87.02 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $76.86 | 2022-2024 | Third Wave, Thinprep 2000 Processor |
| Organon LLC | $65.89 | 2022-2025 | Nexplanon |
| Abbvie INC. | $65.39 | 2021-2022 | |
| Therapeuticsmd, INC. | $45.58 | 2020-2021 | |
| Astellas Pharma US INC | $36.87 | 2023-2025 | Veozah |
| Pfizer INC. | $34.67 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.02 | 2022-2023 | |
| Dexcom, INC. | $26.21 | 2024 | Dexcom G6 Transmitter |
| Lupin INC. | $15.99 | 2020 | |
| Boston Scientific Corporation | $15.40 | 2025 | Bulkamid |
| Coopersurgical, INC. | $13.24 | 2019 | |
| Merck Sharp & Dohme LLC | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Glover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.